The worst had passed, but the pandemic was not yet finished
Em outubro de 2021, o Brasil alcançou uma virada simbólica e concreta: mais de 100 milhões de cidadãos completamente vacinados contra a COVID-19, superando os Estados Unidos em cobertura vacinal. O país que havia enfrentado um dos piores momentos da pandemia — com mais de três mil mortes diárias em abril — via agora os números recuarem de forma dramática, como resultado de uma campanha que, após um início lento, ganhou força e escala. É o retrato de uma nação que, diante do abismo, encontrou o caminho de volta — mas que ainda carrega a consciência de que a travessia não está encerrada.
- O Brasil registrava 3.124 mortes diárias em abril de 2021; em outubro, esse número havia caído para 300 — uma redução de 90% que representa, concretamente, milhares de vidas preservadas.
- Os casos novos despencaram de 77.000 por dia em julho para 11.000 em outubro, e as UTIs, que antes operavam em colapso, voltaram a funcionar abaixo de 50% de ocupação na maioria dos estados.
- A taxa de transmissão, que chegou a 1,23 na segunda onda, caiu para 0,60 — abaixo de 1, o limiar a partir do qual o vírus começa a perder força e a epidemia se contrai.
- Com o Carnaval e o Réveillon no horizonte, especialistas e a Fundação FioCruz alertam: o alívio pode se tornar armadilha se a vacinação perder ritmo e as medidas preventivas forem abandonadas prematuramente.
No início de outubro de 2021, o Brasil ultrapassou a marca de 100 milhões de pessoas completamente vacinadas contra a COVID-19 — um número que, meses antes, parecia distante demais para ser real. Mais do que simbólico, o dado vinha acompanhado de evidências concretas de transformação: o país que havia vivido o pior da pandemia estava, finalmente, recuando da beira do abismo.
A campanha de vacinação começou de forma lenta, limitada pela escassez de doses no primeiro semestre. Mas entre junho e julho o ritmo se acelerou, chegando a mais de dois milhões de aplicações por dia nos melhores momentos. Em outubro, mais de 150 milhões de brasileiros tinham ao menos uma dose — 72% da população, contra 65% nos Estados Unidos, que haviam liderado o processo global mas viram seu ímpeto arrefecer desde abril.
Os números da doença contavam a mesma história. As mortes, que chegaram a uma média de 3.124 por dia em abril, caíram para cerca de 300 em outubro. Os casos novos recuaram de 77.000 para 11.000 diários. As UTIs, que haviam entrado em colapso em quase todos os estados, voltavam a operar com folga. Apenas o Espírito Santo e o Distrito Federal ainda registravam ocupação acima de 75%. As vacinas estavam cumprindo seu propósito: os casos graves e as mortes se concentravam entre os não vacinados e os com esquema incompleto.
O índice de transmissão, monitorado pelo Imperial College de Londres, havia caído de 1,23 durante a segunda onda para 0,60 — o menor nível desde o início do acompanhamento, em abril de 2020. Com a taxa abaixo de 1, o vírus perdia força a cada ciclo de contágio.
Mas os especialistas resistiam à tentação do triunfalismo. A FioCruz alertava que a proximidade das festas de fim de ano e do Carnaval criava um risco real de retrocesso. A recomendação era manter o ritmo de vacinação, completar os reforços, preservar o uso de máscaras em ambientes fechados e exigir comprovante vacinal em grandes eventos. O pior havia ficado para trás — mas o vírus ainda não havia terminado com o Brasil.
By early October 2021, Brazil had reached a milestone that seemed unthinkable just months earlier: more than 100 million citizens fully vaccinated against COVID-19. The number itself was symbolic, but what made it matter was what the data showed alongside it. The country that had been ravaged by the virus—that had seen hospitals overflow and death tolls climb to unimaginable heights—was now pulling back from the edge.
The vaccination campaign had gained momentum through the summer after a sluggish start. In the first half of the year, shortages of doses had constrained the rollout, but by June and July, the pace accelerated dramatically. On the best days, more than two million Brazilians received a shot. By October, over 150 million people had received at least one dose, putting Brazil ahead of the United States in vaccination coverage. While 65 percent of Americans had taken their first dose, more than 72 percent of Brazilians had done so. The Americans, who had peaked in their daily vaccination rate back in April, had since seen that momentum fade. Brazil's trajectory pointed upward.
The human toll of the pandemic had been staggering. In April 2021, at the worst moment, Brazil recorded a seven-day average of 3,124 deaths per day. By October, that number had fallen to around 300—a reduction of roughly 90 percent. The last time the country had seen daily death rates that low was November 2020, when the first wave was receding. Cases had followed a similar arc. In July, Brazil had peaked at 77,000 new diagnoses daily. By October, that figure had dropped to 11,000, a decline of nearly 85 percent. These were not small shifts in the numbers. They represented thousands of lives.
The strain on the health system had eased visibly. Intensive care units across most Brazilian states were now operating below 50 percent capacity—a far cry from the crisis months when nearly every state was painted red on epidemiological maps, signaling maximum alert. Only Espírito Santo and the Federal District remained in serious condition, with occupancy rates above 75 percent. The vaccines, which had been designed and tested precisely to prevent severe illness requiring hospitalization, were doing their job. Studies showed that hospitalizations and deaths were concentrating among the unvaccinated and those with incomplete vaccination schedules.
Another measure told the same story. The Imperial College in London tracked transmission rates—how many people each infected person would infect. In March, when the second wave was building, that rate had climbed above 1.23, meaning 100 infected people would spread the virus to 123 others. By October, it had fallen to 0.60. At that level, the virus was losing momentum; each 100 infected people were transmitting to only 60 others. When the transmission rate stays below 1, the outbreak begins to contract. Brazil had not seen rates this low since the tracking began in April 2020.
Yet experts were careful not to declare victory. The mood among epidemiologists and public health officials was one of cautious optimism—a phrase that acknowledged both the genuine progress and the fragility of it. Eighteen months into the pandemic, exhaustion was real. People were tired of restrictions, tired of masks, tired of fear. The prospect of New Year's celebrations and Carnival created pressure to open up completely. But the FioCruz Foundation, Brazil's leading public health research institute, warned that this moment of relief could become dangerous if vigilance slipped. The recommendation was clear: maintain vaccination momentum, complete booster schedules, keep wearing quality masks in enclosed spaces, avoid crowded indoor settings, and require proof of vaccination for large gatherings. The worst had passed, but the pandemic was not yet finished with Brazil.
Citas Notables
After 18 months of pandemic, population exhaustion and the urgency of resuming activities may lead to relaxation of measures, creating a false impression that it is time for complete reopening— FioCruz COVID-19 Observatory Bulletin
While the country moves toward ideal vaccination coverage, physical distancing, mask use, and hand hygiene should be maintained, and activities with large gatherings should require proof of vaccination— FioCruz public health experts
La Conversación del Hearth Otra perspectiva de la historia
What made the difference between Brazil's early struggles and this October turnaround?
The vaccines arrived late and in small quantities at first, which held everything back. But once the supply chain stabilized in June, the campaign accelerated dramatically. Two million shots a day—that's the kind of scale that changes the curve.
So it's purely a vaccination story?
Mostly, yes. The data is pretty clear: as vaccination went up, deaths and cases went down in lockstep. But there's also something about timing. By October, people had been living with this for eighteen months. Behavior was changing whether restrictions existed or not.
The transmission rate dropping from 1.23 to 0.60—what does that actually mean for someone living through it?
It means the virus is losing its grip. At 1.23, every infected person was spreading it to more than one other person on average, so the outbreak was growing. At 0.60, it's shrinking. The math is relentless.
But the experts said cautious optimism. What were they worried about?
Fatigue. After eighteen months, people want their lives back. They want to gather, celebrate, not think about masks anymore. The risk was that people would interpret the good numbers as permission to abandon all precautions, and then a new variant or a lapse in vaccination could reverse everything.
Did Brazil actually avoid that?
That's the question the story leaves open. The data in October was encouraging, but the warning was real. It depended on what happened next—whether people kept getting vaccinated, whether they maintained basic protections, whether the virus gave them the chance.